These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15581204)

  • 21. Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae.
    Bahr GM; Shaaban MA; Gabriel M; al-Shimali B; Siddiqui Z; Chugh TD; Denath FM; Shahin A; Behbehani K; Chedid L
    Tubercle; 1990 Dec; 71(4):259-66. PubMed ID: 2267679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.
    Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis.
    Davies MG; Symons C; Shaw S; Kaminski ER
    J Dermatolog Treat; 2006; 17(2):74-7. PubMed ID: 16766329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis.
    Stanford JL; Bahr GM; Rook GA; Shaaban MA; Chugh TD; Gabriel M; al-Shimali B; Siddiqui Z; Ghardani F; Shahin A
    Tubercle; 1990 Jun; 71(2):87-93. PubMed ID: 2219469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659.
    Stanford JL; Stanford CA
    Immunobiology; 1994 Oct; 191(4-5):555-63. PubMed ID: 7713570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV; Butov DA; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Hum Vaccin Immunother; 2013 Sep; 9(9):1852-6. PubMed ID: 23782489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
    van Zyl-Smit RN; Esmail A; Bateman ME; Dawson R; Goldin J; van Rikxoort E; Douoguih M; Pau MG; Sadoff JC; McClain JB; Snowden MA; Benko J; Hokey DA; Rutkowski KT; Graves A; Shepherd B; Ishmukhamedov S; Kagina BMN; Abel B; Hanekom WA; Scriba TJ; Bateman ED
    Am J Respir Crit Care Med; 2017 May; 195(9):1171-1180. PubMed ID: 28060545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U; Butov DO; Kutsyna GA; Damdinpurev N; Grinishina EA; Mijiddorj O; Kovolev ME; Baasanjav K; Butova TS; Sandagdorj M; Batbold O; Tseveendorj A; Chunt E; Zaitzeva SI; Stepanenko HL; Makeeva NI; Mospan IV; Pylypchuk VS; Rowe JL; Nyasulu P; Jirathitikal V; Bain AI; Tarakanovskaya MG; Bourinbaiar AS
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):13-9. PubMed ID: 9068812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung.
    Stanford JL; Stanford CA; O'Brien ME; Grange JM
    Eur J Cancer; 2008 Jan; 44(2):224-7. PubMed ID: 17928219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):21-9. PubMed ID: 9068813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages.
    Arkwright PD; David TJ
    Br J Dermatol; 2003 Nov; 149(5):1029-34. PubMed ID: 14632810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis].
    Luo Y; Lu S; Guo S
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):85-8. PubMed ID: 11778496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B; Garner P
    Cochrane Database Syst Rev; 2001; (1):CD001166. PubMed ID: 11279709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae.
    Balagon MV; Walsh DS; Tan PL; Cellona RV; Abalos RM; Tan EV; Fajardo TT; Watson JD; Walsh GP
    Int J Dermatol; 2000 Jan; 39(1):51-8. PubMed ID: 10651968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G; Garner P
    Cochrane Database Syst Rev; 2003; (1):CD001166. PubMed ID: 12535403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial.
    Brothers S; Asher MI; Jaksic M; Stewart AW
    Clin Exp Dermatol; 2009 Oct; 34(7):770-5. PubMed ID: 19438539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiographic improvement and its predictors in patients with pulmonary tuberculosis.
    Heo EY; Chun EJ; Lee CH; Kim YW; Han SK; Shim YS; Lee HJ; Yim JJ
    Int J Infect Dis; 2009 Nov; 13(6):e371-6. PubMed ID: 19328733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.